7 min read
Monthly FDA Guidance and Regulatory News Review - April 2026
This April 2026 regulatory update highlights new policies on biomarker validation, expanded access to investigational...
Meet our experienced #Veristat Head of Global Medical Affairs, Atalah Haun, MD, at the " Advanced Therapies Europe 2022" in London from August 31st -1 September 2022. Don´t miss the opportunity to discuss your clinical program with Veristat.
With more than 27 years of experience in clinical trial planning and execution, Veristat is equipped to support any development program.
Whether you have a compound and need to get started on your IND, or want to recruit patients quickly to get your early phase trials running, or just need medical writing or biostatistical support for your programs - Veristat can help.
We provide impactful drug development and regulatory solutions on both a full-service or functional service basis.
Schedule a meeting with Atalah Haun, MD by filling out the form on the right. Find out how we can help you advance your next clinical trial or regulatory submission to successful outcomes.
Website: https://www.esmo.org/meetings/esmo-congress-2022/registrationhttps://informaconnect.com/bioeurope/
9th-13th September 2022 , Paris

7 min read
May 20, 2026 Veristat Blog
This April 2026 regulatory update highlights new policies on biomarker validation, expanded access to investigational...
3 min read
Apr 27, 2026 Veristat Blog
When an oncology drug is tested, the signal is often brutally clear. A tumor either shrinks on a scan or it does not. A...